US Stock MarketDetailed Quotes

ABVX Abivax S.A.

Watchlist
  • 8.890
  • +0.590+7.11%
Close Dec 4 16:00 ET
  • 8.890
  • 0.0000.00%
Post 20:01 ET
559.37MMarket Cap-2466P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    This_Guy
    This_Guy
    Sep 25 15:05
    $Abivax S.A. (ABVX.US)$
    Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
    Abivax has announced initial preclinical combination data of obefazimod and etrasimod in an inflammatory bowel disease (IBD) mouse model. The company is conducting studies with multiple oral and injectable therapies, with additional data expected in Q4 2024. The p...
Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data